Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Maternal and child outcomes reported by breastfeeding women following mRNA COVID-19 vaccination

Kerri Bertrand, Gordon Honerkamp-Smith, Christina Chambers
doi: https://doi.org/10.1101/2021.04.21.21255841
Kerri Bertrand
1Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kdutcher{at}health.ucsd.edu
Gordon Honerkamp-Smith
1Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Chambers
1Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093
2Herbert Wertheim School of Public Health and Longevity Science, University of California, San Diego, La Jolla, CA 92093
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

What’s known on this subject One published U.S. study with 31 breastfeeding women who were vaccinated with either of the two available mRNA COVID-19 vaccines found that 67% experienced any side effects after dose one and 61% after dose two of the vaccine.

What this study adds More than 85% of 180 breastfeeding women who received an mRNA COVID-19 vaccine reported local or systemic symptoms, with higher frequency following the second dose. Few symptoms were reported in their breastfed children. No serious adverse events were noted.

Contributors’ Statement Page Dr. Chambers and Ms. Bertrand designed the study and supervised the collection of data used in the study. Mr. Honerkamp-Smith performed the statistical analysis. All authors were involved in preparing the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

Competing Interest Statement

Dr. Chambers receives research funding from the following industry sponsors and a foundation: Amgen Inc.; AstraZeneca; Celgene; GlaxoSmithKline; Janssen Pharmaceuticals; Pfizer, Inc.; Regeneron; Hoffman La-Roche-Genentech; Genzyme Sanofi-Aventis; Takeda Pharmaceutical Company Limited; Sanofi; UCB Pharma, USA; Sun Pharma Global FZE; Gilead; and the Gerber Foundation.

Funding Statement

Funding for this study was in part provided by a supplement to NIH-NICHD R21 Grant Number 1R21HD104412-01 to Christina Chambers

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the University of California San Diego institutional review board and all participating women provided written informed consent.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Conflict of Interest Disclosures Dr. Chambers receives research funding from the following industry sponsors and a foundation: Amgen Inc.; AstraZeneca; Celgene; GlaxoSmithKline; Janssen Pharmaceuticals; Pfizer, Inc.; Regeneron; Hoffman La-Roche-Genentech; Genzyme Sanofi-Aventis; Takeda Pharmaceutical Company Limited; Sanofi; UCB Pharma, USA; Sun Pharma Global FZE; Gilead; and the Gerber Foundation.

  • Funding/Support Funding for this study was in part provided by a supplement to NIH-NICHD R21 Grant Number 1R21HD104412-01 to Christina Chambers

Data Availability

Data access may be provided, with appropriate ethics approval, by contacting the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 25, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Maternal and child outcomes reported by breastfeeding women following mRNA COVID-19 vaccination
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Maternal and child outcomes reported by breastfeeding women following mRNA COVID-19 vaccination
Kerri Bertrand, Gordon Honerkamp-Smith, Christina Chambers
medRxiv 2021.04.21.21255841; doi: https://doi.org/10.1101/2021.04.21.21255841
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Maternal and child outcomes reported by breastfeeding women following mRNA COVID-19 vaccination
Kerri Bertrand, Gordon Honerkamp-Smith, Christina Chambers
medRxiv 2021.04.21.21255841; doi: https://doi.org/10.1101/2021.04.21.21255841

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pediatrics
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3297)
  • Dentistry and Oral Medicine (364)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13381)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5155)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3271)
  • Health Policy (1142)
  • Health Systems and Quality Improvement (1192)
  • Hematology (432)
  • HIV/AIDS (1018)
  • Infectious Diseases (except HIV/AIDS) (14632)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (524)
  • Neurology (4928)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (726)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4216)
  • Public and Global Health (7507)
  • Radiology and Imaging (1706)
  • Rehabilitation Medicine and Physical Therapy (1014)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)